Arterial Occlusive Diseases

Showing 26 - 50 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronary Artery Disease, Coronary Disease, Myocardial Ischemia Trial in Israel, United States (CorPath-assisted Percutaneous

Completed
  • Coronary Artery Disease
  • +7 more
  • CorPath-assisted Percutaneous Coronary Intervention
  • San Diego, California
  • +15 more
Dec 1, 2020

Peripheral Arterial Disease, Peripheral Vascular Diseases, Arterial Occlusive Diseases Trial in United States (PTA (Lutonix® 035

Completed
  • Peripheral Arterial Disease
  • +2 more
  • PTA (Lutonix® 035 DCB Catheter)
  • Alexander City, Alabama
  • +72 more
May 12, 2020

Arterial Occlusive Diseases Trial in Dusseldorf, Lingen (ByCross Atherectomy and Thrombectomy)

Completed
  • Arterial Occlusive Diseases
  • ByCross Atherectomy and Thrombectomy
  • Dusseldorf, Germany
  • +1 more
Apr 13, 2020

Legflow in Peripheral Arteries

Not yet recruiting
  • Peripheral Arterial Disease
  • +5 more
  • Drug Coated Balloon
  • Monza, Italy
  • +6 more
Nov 21, 2019

Peripheral Arterial Disease, Intermittent Claudication, Arteriosclerosis Trial in Palo Alto (Patient reported outcomes)

Unknown status
  • Peripheral Arterial Disease
  • +9 more
  • Patient reported outcomes
  • Palo Alto, California
  • +1 more
May 2, 2019

Aorto-iliac Stenosis, Arterial Occlusive Diseases Trial in Ismaning (Gadodiamide Injection)

Completed
  • Aorto-iliac Stenosis
  • Arterial Occlusive Diseases
  • Gadodiamide Injection
  • Ismaning, Germany
    Amersham Buchler GmbH & Co. KG
Apr 24, 2019

Ischemia, Peripheral Arterial Disease (PTA, Arterial Occlusive Diseases Trial in Australia, Netherlands, New Zealand (Absorb

Terminated
  • Ischemia
  • +2 more
  • Absorb Bioresorbable Vascular Scaffold
  • Sydney, New South Wales, Australia
  • +3 more
Apr 15, 2019

Metabolic Syndrome X, Atherosclerosis, Insulin Resistance Trial in Austin (Prolonged sitting without exercise, Prolonged sitting

Completed
  • Metabolic Syndrome X
  • +9 more
  • Prolonged sitting without exercise
  • Prolonged sitting with interval exercise
  • Austin, Texas
    University of Texas at Austin Human Performance Laboratory
Feb 25, 2019

Arterial Occlusive Diseases, Coronary Disease, Heart Diseases Trial in Worldwide (320 Volume Detector Computed Tomography,

Completed
  • Arterial Occlusive Diseases
  • +7 more
  • 320 Volume Detector Computed Tomography
  • Other: Multidetector Computed Tomography - 320 detectors
  • Baltimore, Maryland
  • +15 more
Aug 31, 2018

Evidence of Liver Transplantation, Arterial Occlusive Diseases, Hypertension Trial in Seattle (GE LOGIQ E9 Ultrasound System)

Completed
  • Evidence of Liver Transplantation
  • +4 more
  • GE LOGIQ E9 Ultrasound System
  • Seattle, Washington
    University of Washington
Apr 28, 2018

Late Stent Strut Apposition and Coverage After Drug-Eluting

Unknown status
  • Coronary Artery Disease
  • +7 more
  • Everolimus-Eluting stent
  • Zotarolimus-Eluting stent
  • Daegu, Korea, Republic of
    Keimyung University Dongsan Medical Center
Jan 22, 2018

Coronary Artery Disease, Cardiovascular Diseases, Myocardial Ischemia Trial in Shanghai (Quantitative Flow Ratio (QFR))

Unknown status
  • Coronary Artery Disease
  • +6 more
  • Quantitative Flow Ratio (QFR)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jan 19, 2018

Arterial Occlusive Diseases Trial in Beijing (dyna-pbv)

Unknown status
  • Arterial Occlusive Diseases
  • dyna-pbv
  • Beijing, China
    Peking Union Medical College Hospital
Aug 11, 2017

The FAVOR II China Study

Completed
  • Coronary Artery Disease
  • +7 more
  • Fractional Flow Reserve (FFR)
  • Beijing, Beijing, China
  • +4 more
Jul 25, 2017

Atherosclerosis, Anemia, Aortic Aneurysm, Abdominal Trial in Slagelse (red blood cell transfusion)

Completed
  • Atherosclerosis
  • +3 more
  • red blood cell transfusion
  • Slagelse, Region Zealand, Denmark
    Slagelse Hospital
Jul 22, 2017

Arterial Occlusive Diseases, Myocardial Ischemia, Cardiovascular Diseases Trial in Kanagawa (MDT-4107 Zotarolimus-Eluting

Completed
  • Arterial Occlusive Diseases
  • +3 more
  • MDT-4107 Zotarolimus-Eluting Coronary Stent
  • Kanagawa, Japan
    Shonan Kamakura General Hospital
Feb 3, 2017

Cardiovascular Diseases, Peripheral Vascular Disease, Arterial Occlusive Diseases Trial in United States (Paclitaxel

Completed
  • Cardiovascular Diseases
  • +4 more
  • Paclitaxel administration using the OPC
  • Fairhope, Alabama
  • +3 more
Feb 24, 2017

Monitor Everolimus-eluting Bioresorbable Vascular Scaffold in

Completed
  • Cardiovascular Diseases
  • +9 more
    • Bernau, Germany
    • +5 more
    Dec 8, 2016

    Arterial Occlusive Diseases Trial in Toledo (Plasmin (Human) 25 mg, Plasmin (Human) 50 mg, Plasmin (Human) 75 mg)

    Completed
    • Arterial Occlusive Diseases
    • Plasmin (Human) 25 mg
    • +6 more
    • Toledo, Ohio
      Jobst Vascular Institute
    Oct 28, 2016

    Arterial Occlusive Diseases Trial (procedure, drug, device)

    Unknown status
    • Arterial Occlusive Diseases
    • Continuous peripheral sciatic nerve block
    • +3 more
    • (no location specified)
    Jul 21, 2016

    Arterial Occlusive Diseases, Cardiovascular Diseases, Heart Diseases Trial (niacin, pravastatin, beta-carotene)

    Completed
    • Arterial Occlusive Diseases
    • +4 more
    • (no location specified)
    Jul 11, 2016

    Coronary Artery Disease, Myocardial Ischemia, Coronary Disease Trial in Basel (eSVS Mesh)

    Terminated
    • Coronary Artery Disease
    • +7 more
    • eSVS Mesh
    • Basel, Switzerland
      University Hospital
    Jun 28, 2016

    Framingham Heart Study

    Completed
    • Cardiovascular Diseases
    • +9 more
      • (no location specified)
      Apr 13, 2016

      Blood Factors and Peripheral Arterial Disease Outcomes

      Completed
      • Arterial Occlusive Diseases
      • +3 more
        • (no location specified)
        Mar 15, 2016

        Etiology and Prevalence of Peripheral Arterial Disease

        Completed
        • Cardiovascular Diseases
        • +2 more
          • (no location specified)
          Feb 26, 2016